Statin use vs. average non-HDL cholesterol levels in South Korea

South Korea: Statin use vs. average non-HDL cholesterol levels was 3.4 in 2018. ▬ Flat

Latest (2018)
3.4
Change on year
down 2.9%
World rank
75th
of 191 countries
All-time high
3.6
in 1984
All-time low
3.4
in 2018
Years of data
39
1980–2018

Statin use vs. average non-HDL cholesterol levels in South Korea, 1980–2018

012341980199920181980: 3.51981: 3.51982: 3.51983: 3.51984: 3.61985: 3.61986: 3.61987: 3.61988: 3.61989: 3.61990: 3.61991: 3.61992: 3.61993: 3.61994: 3.61995: 3.61996: 3.61997: 3.61998: 3.61999: 3.62000: 3.62001: 3.62002: 3.62003: 3.62004: 3.62005: 3.62006: 3.52007: 3.52008: 3.52009: 3.52010: 3.52011: 3.52012: 3.52013: 3.52014: 3.52015: 3.52016: 3.52017: 3.52018: 3.4

Source: World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data.

Analysis

South Korea recorded 3.4 for statin use vs. average non-hdl cholesterol levels in 2018. That is the lowest value across all 39 years on record.

That represents a change of down 2.9% on the previous year and down 2.9% over ten years.

Over the whole period, statin use vs. average non-hdl cholesterol levels in South Korea peaked at 3.6 in 1984 and was at its lowest, 3.4, in 2018.

That places South Korea 75th out of 191 countries with data for 2018, putting it in the middle of the range.

Averages by decade

DecadeAverage LowestHighest Years
1980s 3.56 3.5 3.6 10
1990s 3.6 3.6 3.6 10
2000s 3.56 3.5 3.6 10
2010s 3.49 3.4 3.5 9

Countries ranked near South Korea

  1. 75 Argentina 3.4 compare
  2. 75 Belize 3.4 compare
  3. 75 Brazil 3.4 compare
  4. 75 Chile 3.4 compare
  5. 75 Germany 3.4 compare
  6. 75 Israel 3.4 compare
  7. 75 Japan 3.4 compare
  8. 75 New Zealand 3.4 compare
  9. 75 Nicaragua 3.4 compare
  10. 75 Niue 3.4 compare
  11. 75 North Korea 3.4 compare
  12. 75 Oman 3.4 compare
  13. 75 Peru 3.4 compare
  14. 75 Saudi Arabia 3.4 compare
  15. 75 Sweden 3.4 compare
  16. 75 Switzerland 3.4 compare
  17. 75 Syria 3.4 compare
  18. 75 Tuvalu 3.4 compare
  19. 75 Yemen 3.4 compare

See the full ranking of 191 places →

More reference data data for South Korea

All data for South Korea →

Frequently asked questions

What is statin use vs. average non-hdl cholesterol levels in South Korea?
Statin use vs. average non-hdl cholesterol levels in South Korea was 3.4 in 2018, according to World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data.
What is the highest statin use vs. average non-hdl cholesterol levels recorded in South Korea?
The highest recorded value was 3.6 in 1984.
What is the lowest statin use vs. average non-hdl cholesterol levels recorded in South Korea?
The lowest recorded value was 3.4 in 2018.
How does South Korea rank for statin use vs. average non-hdl cholesterol levels?
South Korea ranks 75th out of 191 countries with data for 2018.
Is statin use vs. average non-hdl cholesterol levels rising or falling in South Korea?
Over the last ten years it is down 2.9%. The long-run trend across the full record is flat.
Where does this South Korea data come from?
The figures come from World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as part of Statin use vs. average non-HDL cholesterol levels. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 39 observations, free to reuse under CC BY 4.0 (Our World in Data).

About this data

Indicator
Statin use vs. average non-HDL cholesterol levels
Source
World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
191 places, 7,449 data points, 1980–2018
Last refreshed

The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.